浏览全部资源
扫码关注微信
1.重庆医科大学附属巴南医院药剂科,重庆 401320
2.重庆医科大学附属巴南医院感染肝病科,重庆 401320
3.重庆医科大学附属巴南医院重症医学科,重庆 401320
4.重庆医科大学附属第三医院药剂科,重庆 401120
Published:15 December 2024,
Received:31 July 2024,
Revised:19 October 2024,
移动端阅览
谭瑞,邹婷婷,孙伟等.多学科协作诊疗持续药学监护系统在抗感染治疗患者中的应用 Δ[J].中国药房,2024,35(23):2936-2940.
TAN Rui,ZOU Tingting,SUN Wei,et al.Application of the multi-disciplinary treatment-based continuous pharmaceutical care system in patients undergoing anti-infection treatment[J].ZHONGGUO YAOFANG,2024,35(23):2936-2940.
谭瑞,邹婷婷,孙伟等.多学科协作诊疗持续药学监护系统在抗感染治疗患者中的应用 Δ[J].中国药房,2024,35(23):2936-2940. DOI: 10.6039/j.issn.1001-0408.2024.23.16.
TAN Rui,ZOU Tingting,SUN Wei,et al.Application of the multi-disciplinary treatment-based continuous pharmaceutical care system in patients undergoing anti-infection treatment[J].ZHONGGUO YAOFANG,2024,35(23):2936-2940. DOI: 10.6039/j.issn.1001-0408.2024.23.16.
目的
2
探索多学科协作诊疗(MDT)持续药学监护系统在抗感染治疗患者中的应用效果。
方法
2
本研究团队通过创新研发一套MDT持续药学监护系统,将其应用于因感染经MDT后的抗感染治疗病例,以此实现持续用药监护模式创新。采用回顾性分析方法,收集重庆医科大学附属巴南医院2021年1-10月重症医学科经传统抗感染MDT的150例患者为对照组,2022年1-10月重症医学科因抗感染治疗实行MDT持续药学监护系统管理的130例患者为干预组。比较两组患者一般资料、持续跟踪管理情况、抗感染治疗转归情况、药品不良反应发生情况、抗菌药物管理相关指标以及相关医务人员对临床药师药学服务的满意度。
结果
2
两组患者一般资料比较,差异均无统计学意义(
P
>0.05)。干预组患者持续跟踪管理比例明显高于对照组(
P
<0.01);且两组持续跟踪管理发起人员、发起原因比较,差异均有统计学意义(
P
<0.05)。干预组抗感染治疗转归情况优于对照组,抗菌药物管理相关指标(总住院时间、抗菌药物使用时间、药品总费用、抗菌药物使用量)低于对照组,医务人员综合满意度高于对照组,差异均有统计学差异(
P
<0.05)。两组患者不良反应发生情况、抗菌药物费用差异均无统计学意义(
P
>0.05)。
结论
2
本系统应用于经MDT后的抗感染治疗患者,可实现以临床药师为核心的持续多学科跟踪管理,有利于提高MDT团队随访效率,提升临床药师药学服务质量,改善治疗结局,促进临床合理使用抗菌药物。
OBJECTIVE
2
To explore the application effects of the multi-disciplinary treatment (MDT)-based continuous pharmaceutical care system in patients undergoing anti-infection treatment.
METHODS
2
This research team innovatively developed an MDT continuous pharmaceutical care system, which was applied to cases of anti-infection treatment following MDT due to infection, aiming to innovate the continuous medication supervision model. A retrospective analysis method was used to collect data from 150 patients in the intensive care unit who underwent conventional anti-infection MDT consultations from January to October 2021 in Banan Hospital Affiliated to Chongqing Medical University, serving as the control group, and 130 patients in the intensive care unit who were under the MDT continuous pharmaceutical care system from January to October 2022 were selected as the intervention group. The general information of the patients, the information continuous tracking management, the outcomes of anti-infection treatment, adverse drug reactions, antibacterial drug management indicators, and the degree of satisfaction of relevant medical staff with the clinical pharmacists’ pharmaceutical services were compared between the two groups.
RESULTS
2
Comparison of general information between the two groups showed no statistically significant differences (
P
>0.05). The proportion of continuous tracking management in the intervention group was significantly higher than in the control group (
P
<0.01), and the differences in the initiators and reasons for continuous tracking management between the two groups were statistically significant (
P
<0.05). The intervention group had better outcomes in anti-infection treatment compared to the control group (
P
<0.05). The antibacterial drug management indicators (total length of hospital stay, duration of antibacterial drug use, total drug costs, and amount of antibacterial drugs used) in the intervention group were significantly lower than in the control group, while overall degree of satisfaction among medical staff was significantly higher in the intervention group than in the control group (
P
<0.05). No statistically significant differences were found in adverse reaction occurrence and antibacterial drug costs between the two groups (
P
>0.05).
CONCLUSIONS
2
The application of this system in patients who underwent anti-infection treatment after MDT can achieve continuous multi-disciplinary tracking management with clinical pharmacists at the core, which is beneficial for promoting the follow-up efficiency of the MDT team, raising the quality of clinical pharmacists’ pharmaceutical services, strengthening treatment outcomes, and promoting the rational use of antibacterial drugs in clinical practice.
多学科协作诊疗持续药学监护系统药学服务抗菌药物跟踪管理满意度
continuous pharmaceutical care systempharmaceutical serviceantibacterial drugtracking managementdegree of satisfaction
谈进,陈小飞,刘玲,等.某三甲综合医院多学科协作诊疗管理实施与医疗质量相结合[J].当代医学,2019,25(3):121-122.
TAN J,CHEN X F,LIU L,et al. The implementation of multi-disciplinary team and medical quality in a Sanjia general hospital[J]. Contemp Med,2019,25(3):121-122.
张会会,韩玲,刘琴,等. 多学科协作诊疗模式在深化医院学科建设的探讨[J]. 中国医院管理,2018,38(10):29-30.
ZHANG H H,HAN L,LIU Q,et al. Discussion of deepe- ning hospital discipline construction by multi-discipline team model[J]. Chin Hosp Manag,2018,38(10):29-30.
高扬,邵雨辰,苏明珠,等. 癌症患者的多学科团队协作诊疗模式研究进展[J]. 中国医院管理,2019,39(3):34-37.
GAO Y,SHAO Y C,SU M Z,et al. Advances in the research of multidisciplinary team cooperative diagnosis and treatment model for cancer patients[J]. Chin Hosp Manag,2019,39(3):34-37.
REGUNATH H,VASUDEVAN A,VYAS K,et al. A qua- lity improvement initiative:developing a multi-disciplinary team for infective endocarditis[J]. Mo Med,2019,116(4):291-296.
WEISER T G,FORRESTER J D,FORRESTER J A. Tactics to prevent intra-abdominal infections in general surgery[J]. Surg Infect (Larchmt),2019,20(2):139-145.
高琪琪. 基于多学科协作团队的急救路径对急诊创伤性休克患者院内抢救反应时间及抢救成功率的影响[J]. 检验医学与临床,2022,19(5):701-703.
GAO Q Q. Influence of first aid path based on multidisciplinary collaborative team on hospital rescue response time and rescue success rate of emergency traumatic shock patients[J]. Lab Med Clin,2022,19(5):701-703.
HAJ-MIRZAIAN A,PATEL B N,FISHMAN E K,et al. Value of multidisciplinary collaboration in acute and chronic pancreatitis[J]. Abdom Radiol (NY),2020,45(5):1458-1467.
潘林丽,武大伟,刘善善,等. 多学科协作模式在医院抗菌药物管理中的应用[J]. 中国感染控制杂志,2024,23(6):719-724.
PAN L L,WU D W,LIU S S,et al. Application of multi-disciplinary team model in the management of hospital antimicrobial management[J]. Chin J Infect Contr,2024,23(6):719-724.
何远学,郭玉娟,韩丽珍. 综合性医院多学科协作会诊精细化管理模式探讨[J]. 海南医学,2015,26(21):3250-3253.
HE Y X,GUO Y J,HAN L Z. Discussion on the fine ma- nagement mode of multidisciplinary team consultation in general hospital[J]. Hainan Med J,2015,26(21):3250-3253.
孙湛,杨丽,邵雨婷,等. 多学科诊疗模式现状分析与思考[J]. 中国卫生质量管理,2018,25(6):37-40.
SUN Z,YANG L,SHAO Y T,et al. Analysis and thinking on the current situation of multidisciplinary diagnosis and treatment mode[J]. Chin Health Qual Manag,2018,25(6):37-40.
徐婉瑛,柏志安. 多学科整合会诊的信息化实践[J]. 中国数字医学,2018,13(8):88-91.
XU W Y,BAI Z A. Information practice of multi-disciplinary integrated consultation[J]. China Digit Med,2018,13(8):88-91.
卫生部抗生素临床药理基地. 抗菌药物临床研究指导原则[J]. 中国临床药理学杂志,1987,3(2):126-130.
Clinical Pharmacology Base of Antibiotics of the Ministry of Health. Introduction special column of clinical trial of antibacterial drugs[J]. Chin J Clin Pharmacol,1987,3(2):126-130.
印荷杨,赵俊. 医院多学科团队研究[J]. 南京医科大学学报(社会科学版),2019,19(6):476-479.
YIN H Y,ZHAO J. A review of multidisciplinary team research in hospitals[J]. J Nanjing Med Univ Soc Sci,2019,19(6):476-479.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution